Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders??? Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional paid-in capital
Accumulated deficit
Total
Balance at Dec. 31, 2019 $ 3 $ 102,789 $ (84,464) $ 18,328
Balance (in Shares) at Dec. 31, 2019 28,811,087      
Issuance of common shares upon vesting of restricted stock units
Issuance of common shares upon vesting of restricted stock units (in Shares) 15,070      
Share based compensation 804 804
Net loss (6,511) (6,511)
Balance at Mar. 31, 2020 $ 3 103,593 (90,975) 12,621
Balance (in Shares) at Mar. 31, 2020 28,826,157      
Balance at Dec. 31, 2020 $ 3 115,008 (103,721) 11,290 [1]
Balance (in Shares) at Dec. 31, 2020 32,272,309      
Issuance of common shares upon vesting of restricted stock units
Issuance of common shares upon vesting of restricted stock units (in Shares) 65,915      
Issuance of common shares upon exercise of warrants, net of financing costs of $366 $ 2 11,591 11,593
Issuance of common shares upon exercise of warrants, net of financing costs of $366 (in Shares) 14,267,250      
Issuance of common stock for board of directors’ compensation 272 272
Issuance of common stock for board of directors’ compensation (in Shares) 173,554      
Share based compensation 919 919
Net loss (4,649) (4,649)
Balance at Mar. 31, 2021 $ 5 $ 127,790 $ (108,370) $ 19,425
Balance (in Shares) at Mar. 31, 2021 46,779,028      
[1] Derived from audited consolidated financial statements